title: Ginsenoside Rg1 as a Promising Adjuvant Agent for Enhancing the Anti-cancer Functions of Granulocytes Inhibited by Noradrenaline
design: Granulocytes from participant 1, 2, and 3 mixed to form Rg1 1. Granulocytes in the Rg1 1 were treated with ginsenoside Rg1 (100 mg/L) at 37 C for 24 h.